Hyderabad Paediatrician Sivaranjani Santosh Stands Firm in ORS Labelling Controversy

In response to a legal notice issued by pharmaceutical companies, Dr. Santosh emphasized that her campaign was motivated exclusively by a commitment to childrens health. She expressed concern that attempts to silence advocates could deter others from addressing critical public health matters. Dr. Santoshs campaign has focused on raising awareness about potential health risks associated with certain pharmaceutical products, sparking debates within the medical and scientific communities.

The legal action taken by the pharmaceutical companies comes amidst growing scrutiny of industry practices and has further intensified discussions surrounding transparency in healthcare. The outcome of this legal dispute may have implications not only for Dr. Santosh but also for the broader movement advocating for patient safety and public health advocacy.